Clinical Trials in Phoenix

Showing 3841-3860 of 8,971 trials

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

NCT03075670

This trial is conducted in Europe and the United States of America. The aim of this trial is to compare the pharmacokinetics (the exposure of the trial drug in the body) of nonacog beta pegol (N9-GP) and ALPROLIX® in patients with haemophilia B.

Congenital Bleeding DisorderHaemophilia B

Novo Nordisk A/S15 participantsStarted Mar 2017

Phoenix, Arizona, United States • Chicago, Illinois, United States • Peoria, Illinois, United States +9 more locations

COMPLETED< 1 mile

Dimethyl Fumarate (DMF) Observational Study

NCT02047097

The primary objective of the study is to determine the incidence, type, and pattern of serious adverse events (SAEs), including but not limited to infections (including opportunistic infections), hepatic events, malignancies, and renal events, and of adverse events (AEs) leading to treatment discontinuation in patients with MS treated with dimethyl fumarate (DMF). Secondary objectives of this study in this population are as follows: To determine dimethyl fumarate (DMF) prescription and utilization patterns in routine clinical practice in patients with multiple sclerosis (MS); To assess the effectiveness of dimethyl fumarate (DMF) on multiple sclerosis (MS) disease activity and disability progression in routine clinical practice as determined by the Expanded Disability Status Scale (EDSS) score and multiple sclerosis (MS) relapse information; and To assess the effect of dimethyl fumarate (DMF) on health-related quality of life, healthcare resource consumption, and work productivity.

Multiple Sclerosis

Biogen5,487 participantsStarted Nov 2013

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Gilbert, Arizona, United States +465 more locations

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

Dimethyl Fumarate (DMF) Observational Study

Find Trials by Condition in Phoenix

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors

A 6 Month Safety Extension Study of MBGS205

rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study

WorkWell: Work-based Activity and Metabolic Health

Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

Proof of Concept Study of Binocular Videogames Versus Patching for Amblyopia

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer

Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease

HBV-HIV Coinfection Research Network

Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy